Please use this identifier to cite or link to this item: https://doi.org/10.3343/alm.2018.38.5.440
Title: Evaluation of the luminex ARIES HSV 1&2 assay and comparison with the FTD neuro 9 and in-house real-time PCR assays for detecting herpes simplex viruses
Authors: Lee, C.K.
Chai, C.N.
Capinpin, S.M.
Ang, A.
Ng, S.Y.
Lee, P.L.
Ng, C.W.S.
Yan, G.
Lee, H.K.
Chiu, L.-L.
Jureen, R.
Yan, B.
Loh, T.P. 
Keywords: Genital infections
Herpes simplex virus
Luminex ARIES
Performance evaluation
Sample-to-result
Skin infections
Issue Date: 2018
Publisher: Seoul National University, Institute for Cognitive Science
Citation: Lee, C.K., Chai, C.N., Capinpin, S.M., Ang, A., Ng, S.Y., Lee, P.L., Ng, C.W.S., Yan, G., Lee, H.K., Chiu, L.-L., Jureen, R., Yan, B., Loh, T.P. (2018). Evaluation of the luminex ARIES HSV 1&2 assay and comparison with the FTD neuro 9 and in-house real-time PCR assays for detecting herpes simplex viruses. Annals of Laboratory Medicine 38 (5) : 440-445. ScholarBank@NUS Repository. https://doi.org/10.3343/alm.2018.38.5.440
Rights: Attribution-NonCommercial 4.0 International
Abstract: Background: Human herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are responsible for a plethora of human diseases, of which cutaneous and mucocutaneous infections are the most prevalent. In its most severe form, HSV infection can cause meningitis/ encephalitis. We compared the Luminex ARIES HSV 1&2 assay (Luminex Corp., Austin, TX, USA), an automated sample-to-result molecular solution, to two non-automated HSV DNA assays. Methods: A total of 116 artificial controls were used to determine the analytical performance of the ARIES assay. Controls were prepared by spiking universal transport medium (UTM) and cerebrospinal fluid (CSF) samples from patients who tested negative for HSV by an in-house HSV-1 and -2 DNA assay with reference materials (SeraCare Life Sciences, MA, USA; ZeptoMetrix Corp., MA, USA). Another 117 clinical samples were then used to compare the clinical performance of the ARIES assay with those of an in-house assay and the FTD Neuro 9 assay (Fast Track Diagnostics, Junglinster, Luxembourg). Results: The analytical sensitivity (95% limit of detection) of the ARIES assay was 318 copies/mL (UTM samples) and 935 copies/mL (CSF samples) for HSV-1 strain 96 and 253 copies/mL (UTM samples) and 821 copies/mL (CSF samples) for HSV-2 strain 09. No cross-reactivity was observed in samples spiked with 14 non-HSV microorganisms. Compared with the reference result (agreement between the in-house and FTD Neuro 9 results), the ARIES assay had overall concordance rates of 98.2% (111/113) and 100% (113/113) for HSV-1 and HSV-2, respectively. Conclusions: The ARIES assay appears to be an excellent alternative for rapid detection and differentiation of HSV in skin and genital infections, meningitis, and encephalitis. © Korean Society for Laboratory Medicine
Source Title: Annals of Laboratory Medicine
URI: https://scholarbank.nus.edu.sg/handle/10635/211941
ISSN: 2234-3806
DOI: 10.3343/alm.2018.38.5.440
Rights: Attribution-NonCommercial 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3343_alm_2018_38_5_440.pdf223.87 kBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

4
checked on Sep 30, 2022

Page view(s)

64
checked on Sep 29, 2022

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons